key: cord-1032020-flsujkl4 authors: Yağcı, Sema; Serin, Erdinç; Acicbe, Özlem; Zeren, Mustafa İsmet; Odabaşı, Merve Sena title: The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐19 date: 2021-02-07 journal: Int J Lab Hematol DOI: 10.1111/ijlh.13479 sha: f7915c9964cad95bd0b3e27e8d76d5b458ee2ccf doc_id: 1032020 cord_uid: flsujkl4 INTRODUCTION: Studies have shown that iron metabolism is affected by coronavirus disease 19 (COVID‐19), which has spread worldwide and has become a global health problem. Our study aimed to evaluate the relationship between COVID‐19 and serum erythropoietin (EPO), hepcidin, and haptoglobin (Hpt) levels with disease severity, and other biochemical values. METHODS: Fifty nine COVID‐19 patients hospitalized in the intensive care unit (ICU) and wards in our hospital between March and June 2020 and 19 healthy volunteers were included in the study. Participants were divided into mild, severe, and critical disease severity groups. Group mean values were analyzed with SPSS according to disease severity, mortality, and intubation status. RESULTS: Hemoglobin (Hb) levels were significantly lower in the critical patient group (P < .0001) and deceased group (P < .0001). The red blood cell distribution width‐coefficient of variation (RDW‐CV) and ferritin values were significantly higher in the intubated (P = .001, P = .005) and deceased (P = .014, P = .003) groups. Ferritin values were positively correlated with disease severity (P < .0001). Serum iron levels were lower in the patient group compared with the reference range. (P < .0001). It was found that the transferrin saturation (TfSat) was lower in the patient group compared with the control group (P < .0001). It was found that the mean EPO of the deceased was lower than the control group and the survived patient group (P = .035). Hepcidin levels were found to be significantly lower in the patient group (P < .0001). Hpt values were found to be significantly lower in the intubated group (P = .004) and the deceased group (P = .042). CONCLUSION: In our study, while serum iron and hepcidin levels decreased in patients diagnosed with COVID‐19, we found that EPO and Hpt levels were significantly lower in critical and deceased patient groups. Our study is the first study examining EPO and Hpt levels in patients diagnosed with COVID‐19. Coronavirus disease 2019 (COVID- 19) , which emerged in Wuhan, China, spread worldwide, became a pandemic, and was declared a global public health emergency by the World Health Organization (WHO). According to the latest WHO epidemiological data, 98.2 million reported cases and million deaths have been recorded worldwide. The number of cases diagnosed is increasing day by day. 1 To date, little information is known about the interaction of SARS-CoV-2 with host iron metabolism. The cytokines IL-1, IL-6, INFγ, and TNFα are potent regulators of iron metabolism, taking part in the cytokine storm in COVID-19. 2, 3 Iron homeostasis in COVID-19 has become a crucial part of COVID-19 disease. COVID-19 involves the lungs, and hypoxemia is the main problem. Iron is required for erythrocytes to be able to carry oxygen, and therefore, the effect of iron metabolism in the prognosis of the disease is vital. The similarity in the distant amino acid sequence between the SARS-CoV-2-spiked glycoprotein cytoplasmic tail 4 and the hepcidin protein and the suggestion of the possibility of SARS-CoV-2 attacking the beta chain of hemoglobin in a biological modeling study has drawn attention to SARS-CoV-2 and iron metabolism. 5 Indeed, it was determined that hyperferritinemia or hypoferritinemia developed in the studies conducted. 6 However, it has not been fully elucidated how iron metabolism is affected in COVID-19. This situation makes it challenging to choose a target for treatment. Although many agents that affect iron metabolism (rhEPO, iron chelators, anti-hepcidin monoclonal antibodies, ferroportin antibodies) are recommended in the treatment, there is no clear evidence. 7 COVID-19 has a high rate of hospitalization and mortality. Identifying patients with the highest risk of severe disease and enabling earlier aggressive interventions are essential in reducing mortality and managing health resources by reducing the need for intensive care. Therefore, some indicators are needed at an early stage for the severity and prognosis of the disease. In our study, we aimed to evaluate the relationship between COVID-19 and serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values. This cross-sectional study was conducted at the İstanbul Sisli University after the institutional ethics committee approved the research plan (date: April 22, 2020 , No 2727 . Written informed consent was obtained from all participants. Consent was obtained from the relatives of the patients who could not give consent. The study included patients who had SARS-CoV-2 RNA detected by reverse transcription polymerase chain reaction (RT-PCR) ( According to this classification: Mild cases are defined as mild pneumonia or fever without pneumonia, other respiratory symptoms. Severe cases are defined as patients meeting any of the following: • Respiratory rate of ≥ 30/min, hypoxia (SpO 2 ≤ 93%), • PaO 2 /FiO 2 ratio < 300. • Lung infiltration over 50% within 24-48 hours. Critical cases are defined as presence of any of the conditions of respiratory failure, septic shock, and/or multiple organ failure requiring mechanical ventilation. Venous blood samples were obtained in the morning after 12 hours of overnight fasting from all subjects who participated in the study. For routine biochemical parameters, venous blood samples collected in gel vacuum tubes (BD) were kept at room temperature for 30 minutes and then centrifuged at 3220×g for 10 minutes, and their serums were separated. In all serum samples, routine biochemical parameters were studied on the Beckman Coulter AU680 device on the day the samples were obtained. Total iron-binding capacity (TIBC) was calculated by summing serum iron level and UIBC levels. Transferrin saturation was calculated with the formula of serum iron/TIBCx100. Serum samples for ferritin were studied on the Beckman Coulter DXI800 device. A whole blood sample taken into K2 EDTA tubes (BD) for hemogram analysis was studied on the Mindray BC6800 device on the same day the samples were obtained. SPSS (Statistical Package for the Social Sciences) 21.0 for Windows program was used for statistical analysis. Statistical alpha significance level was considered as P < .05. If the data showed normal distribution, the Student t test was used for independent 2 groups, and one-way ANOVA tests were used for independent 3 groups to compare group averages. Post hoc analyses were performed for the subgroup analysis of the groups for whom the one-way ANOVA test was performed. If the data did not show normal distribution, the Kruskal-Wallis test was used for independent 3-groups analysis, and the Mann-Whitney U test or Wilcoxon's W test was used for subgroup analysis and comparison of independent 2 groups. Diagnostic values of valuable parameters for different severity cases of COVID-19 patients were assessed by the receiver operating characteristic (ROC) and area under the ROC curve (AUC). In the study, the results of 78 participants, including 59 patients with COVID diagnosis and 19 healthy volunteers, were analyzed. Participants consisted of 34 patients hospitalized in the intensive care unit, 25 patients treated in the ward, and 19 healthy volunteers. Patients were grouped according to disease severity, intubation status, and survival status. The numerical distribution, mean age, and gender distribution of the patients by disease severity are presented in Table 1 . No significant difference was found between the patient groups in terms of mean age, both according to disease severity (P = .636) and survival status (P = .168). No significant difference was also found between the patient groups in terms of gender distribution according to disease severity (P = .916) and survival (P = .482). While 22 patients were intubated, 37 patients were not intubated. Twenty-three patients died, and 36 patients were discharged. A significant difference was observed between the critical patient group and all other groups in terms of mean Hb values (P < .0001). While there was no significant difference between the control group and severe cases (P = .198), Hb values were significantly lower in the deceased patients compared with the survivors (P < .0001). Hb values were lower in intubated patients compared with nonintubated patients (P < .0001). When RDW-CV values were examined, it was observed that there was a significant difference between the critical patient group and the control group, and mild and severe patient groups (P < .01). RDW-CV levels were significantly higher in those who died compared with survivors (P = .014). It was observed that as the severity of the disease increased, the ferritin value increased, and there was a significant increase between the groups (P < .0001). Serum ferritin levels were higher in the deceased patients than in the survivors (P = .003) and higher in intubated patients than in nonintubated patients (P = .005). When serum iron levels were studied according to disease severity, a difference was found between the control group and all groups (P < .001). However, there was no significant difference in serum iron levels in terms of survival (P = .176). When the TIBC and UIBC levels were evaluated, a significant difference was observed between all disease severities (P < .0001). According to disease severity, when UIBC levels were evaluated, no statistical difference was found between the control group and the mild disease group (P = .236). TIBC and UIBC were negatively correlated with disease severity. Both TIBC and UIBC levels were significantly lower in the deceased than survivors (P < .0001). Both TIBC and UIBC levels were significantly lower in those who were intubated compared with those who were not intubated (P < .0001). It was found that transferrin saturation was significantly lower in patients diagnosed with COVID-19 compared to the control group (p|<0.0001). However, when the subgroup analysis was performed, it was observed that this difference was present in the mild-severe patient group (P < .0001), and the means of the critical patient group did not show a statistically significant difference compared with the control group (P = .123). No significant difference was observed in TfSat levels in terms of survival (P = .222). Intubated patients had significantly higher TfSat levels compared with nonintubated patients (P = .026). A significant difference was found between the groups by the disease severity in terms of the mean EPO (P = .007). It was observed that this difference was only between critical patients, the control group (P < .0001), and mild cases (P = .015). EPO values were significantly lower in the deceased patients compared with the survivors (P < .035). A statistically significant difference was observed in hepcidin levels between critical patients and the control group (P < .001). Hepcidin levels were significantly lower in the intubated group than those who were not intubated (P = .005). However, no significant difference was found in hepcidin levels between those who died and those who survived (P = .111). A significant inter-group difference was observed in haptoglobin values according to disease severity (P < .0001). Haptoglobin levels were significantly lower in the deceased patients than in the survivors (P = .042) and significantly lower in those who were intubated than those who were not intubated (P = .004). Mean values of the measured parameters are grouped according to the severity of the disease in Table 2 , according to survival in Table 3 and according to intubation status in Table 4 . The statistical significance of the measured values according to the severity of the patients is given in Table 5 . According to the survival status, when the patient data were evaluated with the ROC curve, the area under the curve was mostly found in the disease severity, ferritin, intubation status, and RDW-CV data ( Figure 1 ). In our study, Hb levels decreased with disease severity, and this decrease was even more remarkable in the intubated and deceased patient group. In a study conducted with 117 patients with a diagnosis of COVID-19, it was found that the Hb values of the patients were relatively lower than the normal reference value and that it was more pronounced in severe and critical patients with mild anemia in most cases. 9 In a meta-analysis conducted by Lippi 15 Our findings support the literature that RDW is an indicator of risk and prognosis. The binding of SARS-CoV-2 to CD147 and CD26 in erythroblasts piques its effects on hematopoiesis. 16 Cavezzi et al 7 pointed out that SARS-CoV-2 can cause sideroblastic anemia with myelodysplastic properties as increased RDW is a reliable marker of myelodysplasia. Although the primary modulator of ferritin levels is the presence of iron, its synthesis can also be regulated by different inflammatory cytokines such as IL-1 and IL-6. 17,18 Production of serum ferritin is affected by the presence of iron, pro-inflammatory cytokines, and hepcidin. 19 Our findings show that serum ferritin level increases and hypoferremia develops in COVID-19 disease. In a meta-analysis by Henry et al, serum ferritin level was found to be significantly higher in the survivors and the severe group compared with the nonsevere group. 20 In the study conducted by Zhao Hepcidin is the primary regulator of iron metabolism, and body iron level is positively correlated with plasma hepcidin concentration. 23, 24 Hepcidin binds to ferroportin and facilitates its degradation, thus reducing the absorption of iron. 25 Upregulation of hepcidin is common after a viral infection, so there is a decrease in iron uptake and an increase in iron storage in macrophages. 26 Hepcidin synthesis is increased with IL-6 and an increasing amount of iron in the body. Hepcidin synthesis is reduced with erythropoi- Abbreviations: EPO, erythropoietin; Hb, hemoglobin; RDW-CV, coefficient of variation of red cell distribution width; TfSat, transferrin saturation; TIBC, total iron-binding capacity; UIBC, unsaturated iron-binding capacity. Abbreviations: EPO, erythropoietin; Hb, hemoglobin; RDW-CV, coefficient of variation of red cell distribution width; TfSat, transferrin saturation; TIBC, total iron-binding capacity; UIBC, unsaturated iron-binding capacity. the hepcidin. Therefore, further studies are needed on hepcidin levels in COVID-19 patients. Erythropoietin is a hormone that regulates erythropoiesis and tissue hypoxia stimulates erythropoietin production. It has been shown that erythropoietin and TNFα have an inverse dependence factor, and exogenous EPO administration can decrease TNFα levels. 29 A low T-cell count is crucial in its ability to combat SARS-CoV-2 infection. 30 SARS-CoV-2 glycoproteins bind to human CD26 and possibly reduce CD26 concentration, 31 and CD26 is known to be involved in T-cell activation. 32 Exogenous EPO releases immature and mature B and T cells from the bone marrow within the first 24 hours after administration, thereby increasing T cells' number. 33 EPO acts by modulating the immune response, 34 increasing T-cell count, 33 and decreasing inflammatory cytokines such as TNFα. 29 EPO has anti-inflammatory and anti-apoptotic effects for many cell types and increases live RBC and hemoglobin production, helping restore oxygenation. 22 There are some limitations to our study. First of all, the relatively small sample size and the fact that the patients' baseline values are not known may cause a deficiency in our evaluation. Also, the nonstandardization of the patients' hospitalization periods may not reflect the changes in iron parameters during the disease process. and iron metabolism has not been fully elucidated yet causes its place in treatment not to be determined. Further studies are needed on this subject. We would like to thank the staff of the Department of Clinical Unit. The authors declare that there is no conflict of interest in this article. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. COVID-19, ECMO, and lymphopenia: a word of caution COVID-19: consider cytokine storm syndromes and immunosuppression COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein COVID-19 disease: ORF8 and surface glycoprotein inhibit heme metabolism by binding to Porphyrin 1 introduction Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention Changes of hematological and immunological parameters in COVID-19 patients Hemoglobin value may be decreased in patients with severe coronavirus disease 2019 Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up Unravelling the debate on heme effects in COVID-19 infections Physiological and pathological population dynamics of circulating human red blood cells Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease Elevated RDW is associated with increased mortality risk in COVID-19. medRxiv Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain Serum ferritin: past, present and future COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis Serum iron level as a potential predictor of COVID-19 severity and mortality: a retrospective study The role of blood disorders in the manifestation of ARDS in COVID 19 and EPO as a potential therapeutic agent Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (80-) Viral infection and iron metabolism Iron overload and hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients Hypoferremia Predicts Hospitalization and Oxygen Demand In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO) Dysregulation of immune response in patients with COVID-19 in Wuhan, China The structure and function of CD26 in the T-cell immune response Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 Bone marrow endothelial cells induce immature and mature B cell egress in response to erythropoietin Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity Beyond erythropoiesis: the anti-inflammatory effects of erythropoietin Erythropoetin as a novel agent with pleiotropic effects against acute lung injury Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects Erythropoietin as candidate for supportive treatment of severe COVID-19 Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study Influence of mild infections on iron status parameters in women of reproductive age Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19